Showing 21 - 40 results of 1,171 for search 'antibody effect function', query time: 0.08s Refine Results
  1. 21

    Effect and mechanism of HER2 antibody-drug conjugate combined with anti-PD-1 antibody in mouse bladder cancer models by HE Shuo, TAO Lu, WU Yue

    Published 2025-07-01
    “…Objective‍ ‍To investigate the synergistic therapeutic effects of HER2 antibody-drug conjugate (HER2-ADC) combined with anti-PD-1 antibody (anti-PD-1) on HER2-expressing bladder cancer and elucidate its regulatory mechanisms on the tumor immune microenvironment. …”
    Get full text
    Article
  2. 22

    Kinetic MUNANA assay reveals functionally relevant antibody epitopes on Influenza A virus neuraminidase by Ilya V. Smirnov, Danica F. Besavilla, Karin Schön, Hannes Axelsson, Davide Angeletti

    Published 2025-05-01
    “…In this study, we propose kinetic MUNANA assay as a tool to identify monoclonal antibodies (mAbs) that specifically target functional epitopes on NA. …”
    Get full text
    Article
  3. 23

    Protective Potential and Functional Role of Antibodies Against SARS-CoV-2 Nucleocapsid Protein by Alexandra Rak, Ekaterina Bazhenova, Polina Prokopenko, Victoria Matyushenko, Yana Orshanskaya, Konstantin V. Sivak, Arina Kostromitina, Larisa Rudenko, Irina Isakova-Sivak

    Published 2025-05-01
    “…Here, the protective effect of anti-N antibodies was studied in Syrian hamsters passively immunized with polyclonal sera raised to N(B.1) recombinant protein. …”
    Get full text
    Article
  4. 24

    Targeted delivery of doxorubicin to B-cell lymphoma using monoclonal antibody-functionalized Chaetoceros biosilica by Ghazal Salari, Ahmad Shadi, Amirhossein Ahmadi, Javid Esfandyari, Hossein Nikmanesh

    Published 2025-05-01
    “…This study investigates the effectiveness of porous biosilica derived from the diatom Chaetoceros sp., functionalized with hydrophilic GPTMS, labeled with CD-19 antibody, and loaded with doxorubicin in targeting Raji cells, a B lymphoid cell line. …”
    Get full text
    Article
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29
  10. 30

    Monitoring the follow-up of autoimmune chronic atrophic gastritis using parietal cell antibodies and markers of gastric function by Maria Piera Panozzo, Antonio Antico, Nicola Bizzaro

    Published 2025-06-01
    “…Recent evidence has suggested that, in monitoring A-CAG, parietal cell antibodies should be associated with an evaluation of gastric function through biochemical and hormonal tests, such as pepsinogens and gastrin 17. …”
    Get full text
    Article
  11. 31

    Preparation of polyclonal antibodies against the EIL3 protein and its expression in soybean seedlings by CHENG Yunqing, WU Zhaoyang, LI Yujie, BAN Meihan, LIU Jianfeng

    Published 2024-12-01
    “…The aim of this study was to prepare EIL3 antibodies, verify their effectiveness and preliminarily explore the biological function of EIL3 in the development of soybean seedlings. …”
    Get full text
    Article
  12. 32

    Effect Of Aegle marmelos on IgM And IgG Antibody Titers in Rattus norvegicus by Kadeq Novita Prajawanti, Arif Rahman Nurdianto, Novia Rahmawati, Yohanes Ardian Kapri Negara

    Published 2023-09-01
    “…Literature studies reveal many functional and bioactive compounds, such as alkaloids, phenolics, coumarins, flavonoids, terpenoids, and other antioxidants. …”
    Get full text
    Article
  13. 33

    Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies by Frank R. Brennan, J. Ryan Polli, Jean Sathish, Melissa Ramones, Babette Wolf, Tilman Schlothauer, Shirley J. Peters, Curtis C. Maier, Changhua Ji, David L. Wensel, Derrick Witcher, Patricia C. Ryan, T. Scott Manetz, Adriano Flora, Brian Soper, Birgit Fogal, Lindsey Dzielak, Xiaoting Wang, Prathap Nagaraja Shastri, Karen Price, Michael Doyle, Nidhi Sharda, Mary Struthers, Maximilian Brinkhaus, Bianca Balbino, Eric Stefanich, Masaki Honda, Jan Terje Andersen, Shermaine Mitchell-Ryan, David P. Humphreys

    Published 2025-12-01
    “…For Fc-modified mAbs, the choice of in vitro and in vivo nonclinical pharmacology and safety models need to account for species differences in FcR expression and function, potentially divergent effects of Fc modifications in humans versus nonclinical species, impact of target and cognate ligand expression patterns, and potential impact of emergent anti-drug antibodies directed against the mAb. …”
    Get full text
    Article
  14. 34
  15. 35

    Evaluating the immune effector functions induced by humanized anti-CD99 antibody in eliminating T lymphoblastic leukemia/lymphoma cells by Kamonporn Kotemul, Ratthakorn Chaiwut, Chaochetdhapada Putpim, Supansa Pata, Witida Laopajon, Chatchai Tayapiwatana, Watchara Kasinrerk, Nuchjira Takheaw

    Published 2025-04-01
    “…Abstract Monoclonal antibodies (mAbs) have emerged as targeted immunotherapies with clinical effectiveness and low adverse effects for various cancers. …”
    Get full text
    Article
  16. 36
  17. 37

    PD-1 monoclonal antibodies as an effective treatment for rare cutaneous malignancies: a case report by Ryan Falk, Wolfram Samlowski, Wolfram Samlowski, Wolfram Samlowski, Amin Hedayat, Amin Hedayat, Amin Hedayat

    Published 2025-06-01
    “…The checkpoint inhibitors pembrolizumab and cemiplimab have been effective treatments for a number of cutaneous malignancies. …”
    Get full text
    Article
  18. 38

    Multivariate quantitative analysis of glycan impact on IgG1 effector functions by Tamara Cvijić, Matej Horvat, Jakob Plahutnik, Ana Golob, Jaka Marušič

    Published 2024-12-01
    “…To the best of our knowledge, this is the first report of a systematic approach to quantitatively understand the multivariate impact of glycosylation on the effector functionality of therapeutic monoclonal antibodies, providing valuable tools for advancing therapeutic protein development.…”
    Get full text
    Article
  19. 39

    Characteristics of Older Individuals with Asthma Being Treated with Biologics by Aetou M, Kiskinov Y, Ratsimba SFN, Barth M, Pizarro C, Bergs I, Spiesshoefer J, Skowasch D, Dreher M

    Published 2025-06-01
    “…Participants aged ≥ 60 years used self-injection less than those aged 50– 59 years.Conclusion: These data help to characterize the specific population of older people receiving biologic therapy for severe asthma, and showed a high rate of comorbidities, polypharmacy, and poor diffusion capacity in this group.Keywords: antibodies, asthma, biologics, elderly, lung function…”
    Get full text
    Article
  20. 40

    Assessment of fetal left ventricular function in pregnancies with Anti-Ro/SSA or Anti-La/SSB antibodies using velocity vector imaging by Min Hou, Dan Xie, Jie Wan, Pin Li, Xuan Zhou

    Published 2025-08-01
    “…Conclusion VVI-derived parameters effectively reflect early alterations in myocardial mechanics in fetuses exposed to anti-Ro/SSA or anti-La/SSB antibodies. …”
    Get full text
    Article